Camson Biotechnologies has reported a 52 per cent increase in net profit at Rs 7.30 crore in the third quarter of this fiscal against Rs 4.81 crore registered in the same period last year. Income rose 49 per cent to Rs 32.33 crore in the third quarter. Mr Dhirendra Kumar, Managing Director, Camson Biotech, said, “we expect the growing awareness among farmers on our zero residue biocides and unique hybrid seeds will continue to drive demand for Camson Biotechnologies' products.”